Lessons learned from a 60,000 square-foot project completed in 11 months

Charting the genomic landscape of T-lineage acute lymphoblastic leukemia patients revealed insights that will guide research and help to lay the foundation for more targeted therapy

Discovery provides potential target for vaccines, treatments

Study highlights poor reporting to the FDA of potentially harmful cosmetic products and calls for better data along with policy changes

Researchers made the unexpected finding that bacteria that mutated to become resistant to quinolone antibiotics also became more resistant to triclosan

The method is an alternative to needle-and-syringe immunization; with further development, it could eliminate the discomfort of an injection as well as the inconvenience and expense of visiting a flu clinic

PNNL-OHSU team part of NCI effort to bring proteogenomics to cancer patients

Scientists at Rutgers and other universities build technology that could lead to rapid discovery of new medicines and biomarkers hidden in genomes

The study published in Nature shows that ketamine blocks a protein responsible for a range of normal brain functions

Previous research has shown that pairing antibiotics can be more effective than using single drugs, but finding these perfect matches has proven elusive

Grant brings NYBC scientists one step closer to developing a preventive vaccine ready for first-in-human trials by 2020

Learn more about the differences between generics and biosimilars